BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 29514220)

  • 1. Long non-coding RNA CASC2 inhibits tumorigenesis via the miR-181a/PLXNC1 axis in melanoma.
    Wang Z; Wang X; Zhou H; Dan X; Jiang L; Wu Y
    Acta Biochim Biophys Sin (Shanghai); 2018 Mar; 50(3):263-272. PubMed ID: 29514220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulated lncRNA CASC2 May Inhibit Malignant Melanoma Development Through Regulating miR-18a-5p/RUNX1.
    Zhang Y; Qian W; Feng F; Cao Q; Li Y; Hou Y; Zhang L; Fan J
    Oncol Res; 2019 Feb; 27(3):371-377. PubMed ID: 29422114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of lncRNA CASC2 facilitates osteosarcoma growth and invasion through miR-181a.
    Ba Z; Gu L; Hao S; Wang X; Cheng Z; Nie G
    Cell Prolif; 2018 Feb; 51(1):. PubMed ID: 29194827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15.
    Liu Y; Cheng T; Du Y; Hu X; Xia W
    BMC Mol Cell Biol; 2020 Sep; 21(1):69. PubMed ID: 32998707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
    Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
    Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. lncRNA CASC2/miR‑18a‑5p axis regulates the malignant potential of nasopharyngeal carcinoma by targeting RBBP8.
    Miao WJ; Yuan DJ; Zhang GZ; Liu Q; Ma HM; Jin QQ
    Oncol Rep; 2019 Mar; 41(3):1797-1806. PubMed ID: 30569153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA CASC2 regulates hepatocellular carcinoma cell oncogenesis through miR-362-5p/Nf-κB axis.
    Zhao L; Zhang Y; Zhang Y
    J Cell Physiol; 2018 Oct; 233(10):6661-6670. PubMed ID: 29319182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA CASC2 Interacts With miR-181a to Modulate Glioma Growth and Resistance to TMZ Through PTEN Pathway.
    Liao Y; Shen L; Zhao H; Liu Q; Fu J; Guo Y; Peng R; Cheng L
    J Cell Biochem; 2017 Jul; 118(7):1889-1899. PubMed ID: 28121023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH; Ma ZH; Wang X
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA CASC2 inhibits ox-LDL-mediated vascular smooth muscle cells proliferation and migration via the regulation of miR-532-3p/PAPD5.
    Wang C; Zhao J; Nan X; Guo Z; Huang S; Wang X; Sun F; Ma S
    Mol Med; 2020 Jul; 26(1):74. PubMed ID: 32698757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA CASC2 enhances cisplatin sensitivity in oral squamous cell cancer cells by the miR-31-5p/KANK1 axis.
    Wang J; Jia J; Zhou L
    Neoplasma; 2020 Nov; 67(6):1279-1292. PubMed ID: 32787433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21.
    Wang P; Liu YH; Yao YL; Li Z; Li ZQ; Ma J; Xue YX
    Cell Signal; 2015 Feb; 27(2):275-82. PubMed ID: 25446261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncRNA-MEG3 Suppresses the Proliferation and Invasion of Melanoma by Regulating CYLD Expression Mediated by Sponging miR-499-5p.
    Long J; Pi X
    Biomed Res Int; 2018; 2018():2086564. PubMed ID: 29808164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Molecular Mechanism of LncRNA-CASC2/miR-155-5p/APC Axis Regulating the Progression of Non-Hodgkin Lymphoma].
    Zheng CJ; Wu ZM; Wang YS; Hou YX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1939-1945. PubMed ID: 33283723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-4500 Regulates PLXNC1 and Inhibits Papillary Thyroid Cancer Progression.
    Li R; Teng X; Zhu H; Han T; Liu Q
    Horm Cancer; 2019 Dec; 10(4-6):150-160. PubMed ID: 31317324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GINS2 was regulated by lncRNA XIST/miR-23a-3p to mediate proliferation and apoptosis in A375 cells.
    Hao YQ; Liu KW; Zhang X; Kang SX; Zhang K; Han W; Li L; Li ZH
    Mol Cell Biochem; 2021 Mar; 476(3):1455-1465. PubMed ID: 33389496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA CASC2 targeting miR-18a suppresses glioblastoma cell growth, metastasis and EMT
    Wang J; Qin C; Zhong C; Wen Y; Ke S; Liao BO
    J Biosci; 2020; 45():. PubMed ID: 32975234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. lncRNA CASC2 inhibits lipopolysaccharide‑induced acute lung injury via miR‑27b/TAB2 axis.
    Li X; Mo J; Li J; Chen Y
    Mol Med Rep; 2020 Dec; 22(6):5181-5190. PubMed ID: 33174006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183.
    Sun J; Liu L; Zou H; Yu W
    Yonsei Med J; 2019 Oct; 60(10):905-913. PubMed ID: 31538425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.